In his 2009 best-selling book, “The Innovator’s Prescription,” Harvard University scholar Clayton Christensen explained why many companies miss out on new waves of innovation. Successful companies with established products will get pushed aside unless managers know how and when to abandon traditional business practices, he said.
Life sciences companies were among those analyzed in the book -- named one of the top 100 leadership and success books to read in a lifetime by Amazon’s editors -- using Christensen’s disruptive innovation model and framework.
On Friday, Ann Christensen, president of the Christensen Institute will be a keynote speaker at the next event in the Indiana Life Sciences Collaboration Conference Series.
“Major changes are more likely to come from firms and organizations outside of its current, established players, perhaps at Google, Apple, Amazon and Samsung. This conference will look at what’s ‘bubbling’ at these potential new additions to the industry mosaic,” said George Telthorst, director of the Center for the Business of LifeSciences.
The conference, “Potential Disruptive Innovators in Healthcare,” will take place from 9 a.m. until 3:15 p.m. at IUPUI’s Hine Hall, 875 W. North St., in Indianapolis. It is the second event in a year-long series organized by the center in the IU Kelley School of Business.